Risks of discontinuation of Bituvi/Bikonprenol Tablets blockers midway
Among the blocking drugs after high-risk HIV (AIDS) exposure, Biktarvy tablets (Biktarvy) are recommended by many guidelines as an option for post-exposure prophylaxis (PEP) or transitional treatment due to its complete ingredients, easy administration and good tolerance. However, some patients may discontinue medication midway due to concerns about side effects, cost issues or subjective misunderstandings during use. This behavior is often accompanied by potentially serious risks.

From a virological perspective, the core significance of blocking drugs is to promptly inhibit the replication and integration of HIV in the body, so as to minimize the risk of infection within the "window period". If the drug is stopped early before the 28-day course of treatment is completed, it is equivalent to allowing the virus to break through the defense barrier and increase the possibility of successful integration and colonization of the virus. Especially in the first two weeks after exposure, it is a critical stage for HIV latency and replication. Stopping medication midway will greatly weaken the preventive effect.
Bitovil is a complete three-drug combination regimen. If the drug is stopped midway, it will not only lead to blockade failure, but may also lead to the risk of drug resistance. If the virus survives low-dose or short-term drug pressure, it has the opportunity to evolve into drug-resistant strains, which will pose greater challenges to future treatment. Overseas data show that even in newly treated patients, the development of drug resistance may limit the selection of subsequent first-line drugs and affect long-term management strategies.
In addition, from the perspective of clinical management, stopping medication midway will also affect the patient's psychological state and compliance. Many patients choose to discontinue medication due to early side effects such as mild gastrointestinal discomfort, but in fact these reactions often gradually resolve as the medication continues. If you stop taking the medicine at will without the guidance of a doctor, you will not only lose the protection of blockade, but also easily lead to anxiety and subsequent health risks.
Reference materials:https://www.biktarvy.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)